LDS/Medical Tests/6-Monoacetylmorphine (6-MAM) Confirmation, Urine

6-Monoacetylmorphine (6-MAM) Confirmation, Urine

Heroin is a derivative of morphine and is also called as diacetylmorphine or diamorphine. The presence of two acetyl groups, allows it to easily penetrate the blood-brain barrier. Heroin has an analgesic potency two to three times that of morphine and the ‘high’ experienced from dopamine release makes it a popular drug of abuse. Heroin is no longer legally available in the United States, but it is still used for rapid relief of pain in other countries. After administration of the heroin, it is rapidly and completely metabolized by sequential deacetylation of two separate ester bonds to 6-monoacetylmorphine (6-MAM) and then to morphine.

Urine immunoassays are typically used to screen patient’s urine for the presence of illicit drugs including opioids and their metabolites. However, these tests suffer from potential cross reactivity from non-illicit drugs and foods and therefore confirmatory testing with mass spectroscopy is necessary to both confirm the presence of opioids and to determine the metabolite pattern which aids in the differentiation of the opioid that was used. Note that conversely some opioids such as oxycodone may not be detected by some immunoassays. It is therefore important to understand what substances are detected, undetectable or subject to false positive cross reactions by the screening assay used by the laboratory.

Due to its very short half-life in circulation (2-6 min), heroin itself is rarely detectable in blood. However, the presence of 6-MAM in urine and other body fluids is a definitive indicator of recent heroin use. 6-MAM is ultimately metabolized to morphine and has a half-life of 6-25 minutes. Therefore, 6-MAM can only be detected in the urine for approximately 8 hours after use. Since acetylcodeine is a common contaminant of heroin, both morphine and low concentrations of codeine are frequently detected in urine after heroin use in addition to 6-MAM. However, the presence of morphine and codeine alone is not sufficient evidence to prove the use of heroin.

  • Confirmation of heroin exposure due to use of drug of abuse
  • Heroin therapy monitoring in patients with chronic pain
Presence of 6-MAM in urine is a definitive indicator of recent heroin use with a detection window of 8-24 hours Absence of 6-MAM in the urine does not rule out heroin use because of its short half-life

Negative

Positive are reported with concentration above cutoff (5 ng/g)

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), Gas-chromatography tandem mass spectrometry.

Urine in sterile container. 

Stability

  • Ambient : 72 hours
  • Refrigerated : 14 days
  • Frozen : 14 days
6-MAM screening test, Urine drug of abuse, urine opioid testing, Morphine, Codeine, Hydromorphone.
2-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Basic Clin Pharmacol Toxicol 2006;98:86–96. [PMID: 16433897]
  • J Appl Lab Med. 2018;2(4):471-472 [PMID: 33636905]
  • N Engl J Med 1984;310:1213–17 [PMID: 6709027]
  • Clin Pharmacokinet 2006;45:401–17. [PMID: 16584286]
  • Clin Chem. 1997 Jan;43(1):235-42. [PMID: 8990259]
  • Langman LJ, Bechtel LK, Meier BM, Holstege C: Chapter 41: Clinical Toxicology. In Tietz Textbook of Clinical Chemistry and
  • Molecular Diagnostics. Edited by N Rifai, AR Horvath, CT Wittwer. Sixth edition. Elsevier, 2018 p 872
  • Kerrigan S, Goldberger BA. Opioids. In: Levine B, editor. Principles of forensic toxicology. 2nd ed. Washington DC: AACC Press; 2010. p. 225–44